Although only tested in rats thus far, the polymer-based treatment could repair tissue that are impacted in a variety of ...

As technology continues to evolve, the potential for innovative approaches to cancer detection and therapy becomes increasingly promising. This Research ...

The protein-like polymer, or PLP, platform is made from a polymer that mimics Nrf2. Once injected intravenously, it finds ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure.

The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has received approval from the National Medical ...

Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the publication of 3 abstracts for poster presentations at the ...

Summit Therapeutics' partner Akeso received FDA approval for penpulimab-kcqx in NPC, while ivonescimab showed strong data in ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

Studying the RNA cargo of exosomes also enables a deeper understanding of disease pathogenesis, with exosomal RNA sequencing ...

Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...